Abstract

In recent months, several SARS-CoV-2 variants have emerged that enhance transmissibility and escape host humoral immunity. Hence, the tracking of viral evolutionary trajectories is clearly of great importance. Little is known about SARS-CoV-2 evolution in nonhuman primate models used to test vaccines and therapies and to model human disease. Viral RNA was sequenced from rectal swabs from Chlorocebus aethiops (African green monkeys) after experimental respiratory SARS-CoV-2 infection. Two distinct patterns of viral evolution were identified that were shared between all collected samples. First, mutations in the furin cleavage site that were initially present in the virus as a consequence of VeroE6 cell culture adaptation were not detected in viral RNA recovered in rectal swabs, confirming the necessity of this motif for viral infection in vivo. Three amino acid changes were also identified; ORF 1a S2103F, and spike D215G and H655Y, which were detected in rectal swabs from all sampled animals. These findings are demonstrative of intra-host SARS-CoV-2 evolution and may identify a host-adapted variant of SARS-CoV-2 that would be useful in future primate models involving SARS-CoV-2 infection.

Highlights

  • The COVID-19 pandemic, caused by the coronavirus SARS-CoV-2, has killed more than 4 million people to date

  • Eight RhM and eight African green monkeys (AGM) were challenged with SARS-CoV-2, WA1/2020 isolate, as described [22]

  • Rectal swabs isolated from three AGM infections at 2 or 4 weeks post-infection were analyzed in the same fashion

Read more

Summary

Introduction

The COVID-19 pandemic, caused by the coronavirus SARS-CoV-2, has killed more than 4 million people to date. Since the discovery of the D614G mutation [2,3], noted early in the pandemic and found to enable enhanced infection in cells and is present in all sequenced isolates, several variants of interest and concern (as defined by the CDC) have arisen [1,4,5,6,7,8,9,10,11] At the time of this submission, the B.1.1.529 (omicron) is rapidly increasing in frequency and may overtake delta as the globally dominant variant [13,14] These data suggest a concerning scenario wherein continued SARS-CoV-2 evolution may facilitate persistence and spread in populations, including those with preexisting immunity to the virus

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call